GLP-1 weight management
Evaluated and prescribed by the licensed network where appropriate — you run the branded program and never prescribe.
Who it's for
Demand for medical weight loss has never been higher — and the rules have never moved faster. Compounded supply, state prescribing rules and FDA enforcement shift constantly. Wellstaq matches every patient to an independent network licensed in their state that owns the evaluation, the prescribing, and the regulatory call on what can be offered and fulfilled, where permitted. Your durable revenue isn't the drug margin — it's the branded program around it: visits, monitoring, labs, supplements and adjacent hormone care, recurring under your name. When the rules change, that's the network's burden to absorb, not yours.
$0 to start$0 until you're liveno cardcancel anytime
Wellstaq is a white-label clinical platform that lets weight-loss and GLP-1 clinics offer labs, telehealth, 503A Rx and supplements under their own brand, while an independent, board-certified network licensed in all 50 states owns all clinical decisions and prescribing.
Your recurring upside
Start with your core program, then stack the layers you own. Drag the member count and toggle each layer — every figure is illustrative and set by you.
Weight-management program = membership, visits & monitoring — programs typically run $199–$399/mo; shown here at the conservative end.
Illustrative — you set your own pricing. Not a guarantee of earnings. Figures are your recurring program revenue (membership, monitoring, labs, supplements and adjacent care), not promised drug margin. Labs and supplements pass through at wholesale; you set retail and keep the margin. Wellstaq takes 0% of your sales.
At a $199/mo program,
just 11 members
cover your entire $2,000/mo platform fee. Every member after that is your margin.
Illustrative — you set your own pricing. Not a guarantee of earnings.
A proven model
Ro & Hims turned telehealth and recurring prescriptions into billion-dollar brands. You get that same model — plus blood labs, genetic reports and a branded supplement line they don't bundle — under your own name, with an independent 50-state network owning all clinical care.
Billion-dollar brands — built on years of venture capital.
Launch in weeks, for a flat fee — no raise required.
Interest in medical weight loss has never been higher, and the programs are sticky — patients stay for months of visits, labs and refills. What stops clinics from scaling is everything around the prescription: shifting compounding rules, a different GLP-1 prescribing standard in every state, and the FDA and state attorneys general escalating enforcement against do-it-yourself telehealth and "research-grade" sourcing. Wellstaq removes that load — the platform runs your branded program and an independent 50-state network owns the clinical evaluation, the prescribing and the regulatory call on what can be offered and fulfilled, where permitted, so you can grow on demand instead of building a pharmacy.
flat $2,000/mo your cost does not rise as the program scales
Evaluated and prescribed by the licensed network where appropriate — you run the branded program and never prescribe.
Metabolic, A1c and lipid panels via Quest and LabCorp at wholesale; you set retail. The monitoring that keeps members enrolled and the program credible.
Protein, fiber and micronutrient support that protects results between refills — a recurring add-on on your own label, priced by you.
Provider visits for titration and monitoring, delivered by the network inside your branded app — the recurring touchpoints that drive retention.
Many weight patients also screen for hormone issues; the network can evaluate TRT and HRT where appropriate, expanding lifetime value under the same brand.
The fears that stop most weight-loss operators are the exact ones Wellstaq is built to remove. You don't prescribe: an independent, board-certified provider licensed in the patient's own state evaluates the GLP-1 category and owns every prescribing decision. You don't source: the independent network owns the regulatory call on what can be prescribed and fulfilled, where permitted, so the FDA warning letters and state-attorney-general actions aimed at do-it-yourself compounding and "research-grade" supply are not your exposure. And you never touch PHI or carry clinical liability — that sits entirely with the network. You stay the brand, the program and the margin.
Branded intake captures eligibility and health history before any clinical step — your name on the entire experience.
An independent provider licensed in the patient's state evaluates the GLP-1 category, owns prescribing where appropriate, and makes the regulatory call on what can be fulfilled, where permitted — never you.
Labs, supplements, visits and medication access pass through at wholesale; you set retail and keep the margin. Wellstaq charges a flat $2,000/mo and takes 0% of your sales.
You're really choosing between sending patients to someone else's brand, building it all yourself, or owning the model on Wellstaq.
How the economics work
$2,000/mo flat platform fee — the only cut we take. Blood labs, telehealth and supplements pass through at true wholesale cost; you set retail and keep the margin. Wellstaq takes 0% of your sales.
Yes. In the Wellstaq model you never prescribe. An independent, board-certified provider licensed in the patient's state evaluates the GLP-1 category and owns the prescribing decision; you run the branded weight-management program — visits, monitoring, labs and supplements — around it.
It is restricted and still changing. As the FDA-declared shortages of semaglutide and tirzepatide resolved, large-scale compounding of those GLP-1s has been wound down; 503A patient-specific compounding remains available only with a documented clinical need, where permitted. The independent network makes that regulatory call patient by patient — it is not yours to track.
You launch a branded program on the Wellstaq platform: patients intake under your name, an independent licensed network evaluates and prescribes where appropriate, and labs and supplements pass through at wholesale so you set retail and keep the margin. There is no pharmacy to build and no prescribing for you to do.
Yes — you never prescribe. An independent, board-certified provider licensed in the patient's state evaluates the GLP-1 category and owns every prescribing decision. You run the brand and the program.
The independent network does. Its providers — licensed in each patient's state — decide what can be evaluated, prescribed and fulfilled, where permitted, and adapt as FDA and state rules change. You don't carry that regulatory exposure, and your durable revenue is the branded program around the care — visits, monitoring, labs, supplements and adjacent hormone care — not the drug itself.
Each patient is matched to a provider licensed in their own state, so the program stays compliant as you grow nationally — without you tracking a different medical-board rule in all 50 states.
You set retail on your program, labs and supplements and keep the margin over your wholesale cost. Wellstaq charges a flat $2,000/month and takes 0% of your sales. Every figure here is illustrative, not a guarantee of earnings.
The independent network owns the clinical and regulatory response and adapts the available pathways where permitted. Your brand and your member relationships stay intact while the compliance burden stays with the network.
No. The independent network carries clinical liability and handles PHI on HIPAA-compliant systems. You are the brand and the program, never the medical provider of record.
A flat $2,000/mo, wholesale pass-through, and 0% of your sales. Get on the list before spots open.
$0 to start$0 until you're liveno cardcancel anytime
Wellstaq provides technology and brand infrastructure. All clinical decisions, evaluations and prescribing are made by an independent, board-certified provider network licensed in all 50 states. Wellstaq and its partners make no diagnosis, treatment, efficacy or outcome claims; nothing here is medical advice.